Human Dental Pulp Stem Cells Attenuate Neuroinflammation and Neurological Deficit in a Murine Model of Multiple Sclerosis
The FASEB Journal · 2026
DOI: 10.1096/fj.202500080rrrr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Ying Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Dental Pulp, Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental, Stem Cells. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, National Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system mediated by autoimmune demyelination. While treatments targeting the peripheral immune system have been effective in reducing relapse risks for MS patients, the neuroinflammation within the central nervous system, which is believed to contribute to neurodegeneration, has not been successfully addressed. Human Dental Pulp Stem Cells (hDPSCs) have shown potential in entering the CNS and exerting anti‐inflammatory effects, making them a promising candidate for treating neurological disorders. In experimental autoimmune encephalomyelitis (EAE) models, intravenously administered hDPSCs ameliorated clinical scores, decreased demyelinated lesion volume, and reduced inflammatory infiltration. Given the established safety profile, hDPSCs could potentially be developed as a new approach to combat disease progression of MS by inhibiting compartmentalized neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
- Department of Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Orthodontics, Beijing Stomatological Hospital, School of Stomatology, Capital Medical University, Beijing, China.
- Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, Chin…
- Institute for Immunology, Chinese Institutes for Medical Research, Beijing, China.
- Salivary Gland Disease Center and Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Laboratory of Oral Health and School of Stomatology, Capital Medical University, Beijing, China.
ORCID-Profile: Kaibin Shi
Förderung
- Beijing Natural Science Foundation
- National Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Chang, Y., Guan, X., Jiang, S., Su, Y., Wang, H., Zhou, J., Shi, K., Jin, W. N., Wang, Y., Wang, S., & Shi, F. D. (2026). Human Dental Pulp Stem Cells Attenuate Neuroinflammation and Neurological Deficit in a Murine Model of Multiple Sclerosis. The FASEB Journal. https://doi.org/10.1096/fj.202500080rrrr
Vancouver
Zhang Y, Chang Y, Guan X, Jiang S, Su Y, Wang H, et al. Human Dental Pulp Stem Cells Attenuate Neuroinflammation and Neurological Deficit in a Murine Model of Multiple Sclerosis. The FASEB Journal. 2026. doi:10.1096/fj.202500080rrrr
BibTeX
@article{Zhang2026,
author = {Zhang, Ying and Chang, Yingying and Guan, Xiuchen and Jiang, Shihe and Su, Yingying and Wang, Hao and Zhou, Jian and Shi, Kaibin and Jin, Wei-Na and Wang, Yilong and Wang, Songlin and Shi, Fu-Dong},
title = {Human Dental Pulp Stem Cells Attenuate Neuroinflammation and Neurological Deficit in a Murine Model of Multiple Sclerosis},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202500080rrrr}
}
EUVIMED